Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Voyager Therapeutics (VYGR) Other Non Operating Income: 2014-2024

Historic Other Non Operating Income for Voyager Therapeutics (VYGR) over the last 11 years, with Dec 2024 value amounting to $622,000.

  • Voyager Therapeutics' Other Non Operating Income rose 100.00% to $400,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 41.01%. This contributed to the annual value of $622,000 for FY2024, which is 20633.33% up from last year.
  • According to the latest figures from FY2024, Voyager Therapeutics' Other Non Operating Income is $622,000, which was up 20,633.33% from $3,000 recorded in FY2023.
  • Over the past 5 years, Voyager Therapeutics' Other Non Operating Income peaked at $7.7 million during FY2020, and registered a low of $3,000 during FY2023.
  • Moreover, its 3-year median value for Other Non Operating Income was $622,000 (2024), whereas its average is $1.1 million.
  • As far as peak fluctuations go, Voyager Therapeutics' Other Non Operating Income plummeted by 99.89% in 2023, and later surged by 20,633.33% in 2024.
  • Voyager Therapeutics' Other Non Operating Income (Yearly) stood at $7.7 million in 2020, then plummeted by 63.48% to $2.8 million in 2021, then declined by 5.62% to $2.7 million in 2022, then tumbled by 99.89% to $3,000 in 2023, then skyrocketed by 20,633.33% to $622,000 in 2024.